학술논문
Brief Report: Impact of COVID-19 on Cabotegravir Plus Rilpivirine Long-Acting Dosing Across 6 Ongoing Global Phase IIb and III Clinical Trials
Document Type
Article
Author
Source
In: Journal of Acquired Immune Deficiency Syndromes . (Journal of Acquired Immune Deficiency Syndromes, 1 October 2022, 91(2):157-161)
Subject
Language
English
ISSN
10779450
15254135
15254135